David Protein CEO Peter Rahal on the rise of protein bars, impact of GLP-1s and protein intake

Summary

Peter Rahal, CEO and founder of David Protein, discusses the rise of protein bars, the role of GLP-1 weight-loss drugs in driving protein demand, and his company's proprietary EPG modified-triglyceride technology. He explains how David Protein makes high-protein, low-calorie bars and plans to extend EPG into chocolate/cocoa-butter substitution and frying applications. The interview also covers creatine safety, product distribution at Walmart and Target, and the company's ambition to surpass RXBAR. No public-market investment recommendations or named public securities were provided.

• Peter Rahal is CEO and founder of David Protein, a private protein-bar company.
• David Protein sells high-protein, low-calorie bars through its website, Walmart, and Target.
• GLP-1 weight-loss drugs are cited as a tailwind because users need high protein intake.
• The company acquired Epogee/EPG, a modified triglyceride that mimics fat without being metabolized.
• EPG applications include sports nutrition, cocoa-butter substitution, and frying.
• Rahal comments on creatine safety and the difficulty of eating enough protein.
• The interview includes product innovation around whey-protein marshmallow texture.
• No public tickers or tradable investment expressions are named.